21May
21May
KIOXIA and Wasabi Collaborate to Deliver Fast, Intelligent Cloud Object Storage Solution
SAN JOSE, Calif.--(BUSINESS WIRE)--KIOXIA America, Inc. today announced a collaboration with Wasabi Technologies to enhance the speed, reliability, and cost-efficiency of their cloud object storage offering. Since 2022, KIOXIA has worked closely with Wasabi to provide SAS and NVMeTM SSDs for highly performant cloud storage services. As part of this ongoing collaboration, Wasabi is utilizing high-performance enterprise and data center-class NVMe SSDs from KIOXIA for its Hot Cloud Storage Service. Read More>>
14May
If student loan domino falls, what’s next for fintechs in the sector?
As of last week, following policy changes under the Trump Administration, borrowers may see hits to their credit scores, wages garnished, tax refunds seized, and reductions in social security benefits. To make sense of how these changes may affect student loan-focused fintechs, as well as their impact on the debt and financial health of US consumers, we interviewed Laurel Taylor, Founder and CEO of NYC-based student debt and savings optimization platform Candidly. Read More>>
30Apr
Elizabeth Banks And Archer Roose’s Next Act: A New Pinot Noir And Doubling Growth
Archer Roose Wines, co-owned by actress Elizabeth Banks, says the canned wine brand is coming off a record year in 2024. What’s next is a new canned pinot noir, the company’s first new red varietal in five years. Co-founder and CEO Marian Leitner-Waldman tells me during a virtual interview that sales volume for Archer Roose Wines exceeded 100,000 nine-liter cases in 2024, a record for the brand, and is currently hitting a 125,000 annualized case volume on a trailing 12-month average....
25Apr
CytoAgents Announces Completion of Cohort 1 Dose-escalation Stage of Clinical Phase 1B to Advance Research on Cytokine Release Syndrome
PITTSBURGH--(BUSINESS WIRE)--CytoAgents Inc., a clinical-stage biotechnology company developing CTO1681 for the prevention and treatment for Cytokine Release Syndrome (CRS), announced the successful completion of the first dose, core cohort dose-limiting toxicity observation period in its ongoing Phase 1b/2a clinical trial. Following a review of safety and efficacy data, the Safety Review Committee (SRC) has approved dose-escalation to the next, higher planned dose in Cohort 2. “This milestone marks an important step forward in our mission to deliver a safe, effective therapy...
23Apr
Candidly, Fiducius Partner to Offer Student Debt Repayment Benefits
Candidly has partnered with Fiducius, a provider of financial wellness benefits, to add tools for college savings and private student lending to the Fiducius platform. The new relationship will allow Candidly to grow its solutions for planning and paying for college and, in turn, enable Fiducius to reach new employee populations. With the addition of Candidly’s student loan refinancing marketplace, both firms believe the collaboration will drive more value for Fiducius users adjusting their student debt repayment strategy amid ongoing changes...
23Apr
New Episode of Never a Dull Moment – Z-Pods
A new Never a Dull Moment episode has dropped! 🎙️ Our host Ziad Henry Moukheiber sits down with Scott Pancoast CEO and founder of Zylö Therapeutics to discuss Z-Pods and more! Press play to hear about Scott's incredible journey from venture capital to starting a business in biotech and cosmetics. Listen to the full episode here.
05Mar
New Episode of Never a Dull Moment – The CFO
🎙️ Never a Dull Moment podcast has released a new episode! 🎙️ In this conversation, host Ziad Henry Moukheiber chats with guest Michael Bayer, CFO of one of Boston Harbor Angels portfolio companies Wasabi Technologies. This fascinating discussion is kicked off with Michael's description of a CFO as a storyteller. Tune in to hear more about about how the role of CFO has evolved!
17Feb
Light Within the Black Hole of Concussion Therapeutics
Last September, the Fédération Internationale de Football Association (FIFA) and the World Health Organization launched the “Suspect and Protect” concussion awareness campaign. In the past few years, the U.S. Department of Defense, the National Hockey League, and the National Football League each introduced plans to minimize concussions, including updating their concussion protocols. And large pharmaceutical companies have done…little. For companies active in this space, their slow progress may be more related to investors’ misperceptions of the topic than the science itself....
09Jan